Cases of listeriosis were reported among patients undergoing therapy with other biologic agents such as infliximab (antitumor necrosis factor agents) [38–41], etanercept (a tumor necrosis factor antagonist) [42], and trastuzumab (a monoclonal antibody against the HER2 receptor) [43]. Here, TNF is linked to listeriosis.